Dr. Bernhard Ehmer |
|||
---|---|---|---|
Chairman of the Supervisory Board |
|||
Personal Information |
|||
Date of Birth: | 03 February 1955 | ||
Place of Birth: | Kandel, Germany | ||
Nationality: | German | ||
Education |
|||
Faculty of Medicine, Ruprecht-Karls-University of Heidelberg, 1976 - 1982 |
|||
Career |
|||
2014 – 2019 | Biotest AG, CEO | ||
2008 - 2012 | Imclone Group
|
||
2007 - 2008 | Fresenius Biotech, CEO | ||
2006 - 2007 | Biopheresis GmbH & Inc., CEO & Managing Director | ||
1998 - 2006 |
Merck Group
|
||
1986 - 1998 |
Boehringer Mannheim
|
||
1983 - 1986 | Academic Teaching Hospital University of Heidelberg, Resident Internal Medicine |
||
Membership in Supervisory Boards and Comparable Controlling Bodies |
|||
Affimed N.V. – Member of the Board |